Prostate

Publication Title: 
BMJ open

INTRODUCTION: Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate commonly encountered in older men. BPH has been treated with acupuncture inside and outside China, but its effects are uncertain. This review aims to assess the efficacy and safety of acupuncture therapy for BPH.

Author(s): 
Zhang, Wei
Yu, Jinna
Liu, Zhishun
Peng, Weina
Publication Title: 
Revista Brasileira De Anestesiologia

BACKGROUND AND OBJECTIVES: Ultrasound-guided transrectal prostate biopsy is a reference in the diagnosis of prostate neoplasias. The higher the number of samples, the greater is the pain and discomfort. The objective of this study was to compare three anesthetic techniques in this group of patients. METHODS: Forty-five patients were included in this study. Patients were divided into three groups: 1 - Propofol; 2 - Propofol + Prostatic Plexus Block; 3 - Propofol + Fentanyl.

Author(s): 
Barbosa, Ricardo Antônio Guimarães
da Silva, Camerine Domingues
Torniziello, Mary Yumi Takei
Cerri, Luciana Mendes de Olivera
Carmona, Maria José Carvalho
Malbouisson, Luiz Marcelo Sá
Publication Title: 
Cancer Prevention Research (Philadelphia, Pa.)

Prostate cancer remains the second leading cause of cancer deaths among American men. Earlier diagnosis increases survival rate in patients. However, treatments for advanced disease are limited to hormone ablation techniques and palliative care. Thus, new methods of treatment and prevention are necessary for inhibiting disease progression to a hormone refractory state. One of the approaches to control prostate cancer is prevention through diet, which inhibits one or more neoplastic events and reduces the cancer risk.

Author(s): 
Ru, Peng
Steele, Robert
Nerurkar, Pratibha V.
Phillips, Nancy
Ray, Ratna B.
Publication Title: 
Anticancer Research

BACKGROUND: Prostate cancer is one of the most commonly diagnosed solid malignancies among US men. We identified gallic acid (GA) as a major bioactive cytotoxic constituent of a polyherbal Ayurvedic formulation - triphala (TPL). Both TPL and GA were evaluated on (AR)(+) LNCaP prostate cancer and normal epithelial cells. MATERIALS AND METHODS: Total polyphenols in TPL were determined using Folin and Ciocalteu method, followed by GA quantitation by high performance liquid chromatography. Cell toxicity was evaluated by crystal violet after 24, 48, 72 and 96 h.

Author(s): 
Russell, Larry H.
Mazzio, Elizabeth
Badisa, Ramesh B.
Zhu, Zhi-Ping
Agharahimi, Maryam
Millington, Donna J.
Goodman, Carl B.
Publication Title: 
Cancer Prevention Research (Philadelphia, Pa.)

Prostate cancer remains the second leading cause of cancer deaths among American men. Earlier diagnosis increases survival rate in patients. However, treatments for advanced disease are limited to hormone ablation techniques and palliative care. Thus, new methods of treatment and prevention are necessary for inhibiting disease progression to a hormone refractory state. One of the approaches to control prostate cancer is prevention through diet, which inhibits one or more neoplastic events and reduces the cancer risk.

Author(s): 
Ru, Peng
Steele, Robert
Nerurkar, Pratibha V.
Phillips, Nancy
Ray, Ratna B.
Publication Title: 
Cancer Prevention Research (Philadelphia, Pa.)

Prostate cancer remains the second leading cause of cancer deaths among American men. Earlier diagnosis increases survival rate in patients. However, treatments for advanced disease are limited to hormone ablation techniques and palliative care. Thus, new methods of treatment and prevention are necessary for inhibiting disease progression to a hormone refractory state. One of the approaches to control prostate cancer is prevention through diet, which inhibits one or more neoplastic events and reduces the cancer risk.

Author(s): 
Ru, Peng
Steele, Robert
Nerurkar, Pratibha V.
Phillips, Nancy
Ray, Ratna B.
Publication Title: 
Anticancer Research

BACKGROUND: Prostate cancer is one of the most commonly diagnosed solid malignancies among US men. We identified gallic acid (GA) as a major bioactive cytotoxic constituent of a polyherbal Ayurvedic formulation - triphala (TPL). Both TPL and GA were evaluated on (AR)(+) LNCaP prostate cancer and normal epithelial cells. MATERIALS AND METHODS: Total polyphenols in TPL were determined using Folin and Ciocalteu method, followed by GA quantitation by high performance liquid chromatography. Cell toxicity was evaluated by crystal violet after 24, 48, 72 and 96 h.

Author(s): 
Russell, Larry H.
Mazzio, Elizabeth
Badisa, Ramesh B.
Zhu, Zhi-Ping
Agharahimi, Maryam
Millington, Donna J.
Goodman, Carl B.
Publication Title: 
Clinical Therapeutics

BACKGROUND: Drug treatment can defer surgical intervention in benign prostatic hyperplasia (BPH), a common disorder in elderly men, and is widely practiced. Various herbal formulations have been used for the treatment of BPH, but few have been compared with established modern medicines in head-to-head clinical trials. OBJECTIVE: We compared the effectiveness and tolerability of an oral formulation, comprising standardized extracts of Murraya koenigii and Tribulus terrestris leaves being marketed in India under Ayurvedic license, versus tamsulosin in the treatment of symptomatic BPH.

Author(s): 
Sengupta, Gairik
Hazra, Avijit
Kundu, Anup
Ghosh, Anirban
Publication Title: 
Phytotherapy research: PTR

Anacyclus pyrethrum (A. pyrethrum) has been used as Vajikaran Rasayana (aphrodisiac) in traditional Indian ayurvedic medicine to treat male sexual dysfunction, including infertility. Aphrodisiac activity may be due to an increase in the production or effect of androgens, so this study sought to evaluate the androgenic and spermatogenic potential of the alkylamide-rich ethanol solution extract. Male Wistar strain rats weighing between 150 and 180 g were completely randomized divided into five groups. The ethanol solution extract of A.

Author(s): 
Sharma, Vikas
Boonen, Jente
Spiegeleer, Bart De
Dixit, V. K.
Publication Title: 
Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology

Human prostate cancer is characterized by an early and near-universal loss of expression of the phase 2 enzyme glutathione S-transferase-pi (GSTP1). We hypothesize that a mechanism-based prostate cancer preventive strategy could involve induction of phase 2 enzymes within the prostate to compensate for the loss of GSTP1 expression.

Author(s): 
Brooks, James D.
Goldberg, Michael F.
Nelson, Linda A.
Wu, David
Nelson, William G.

Pages

Subscribe to RSS - Prostate